Cerus (CERS) Net Cash Flow Growth (1y) (2011 - 2026)
Cerus (CERS) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 76.43% |
| 10 | Cerus | 605.72 Mn | 525.30 Mn | 27.89 Mn | 931.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 931.91% |
| Dec 31, 2025 | 335.32% |
| Sep 30, 2025 | -102.93% |
| Jun 30, 2025 | 54.82% |
| Mar 31, 2025 | -110.73% |
| Dec 31, 2024 | 72.15% |
| Sep 30, 2024 | 382.95% |
| Jun 30, 2024 | -18.55% |
| Mar 31, 2024 | 210.90% |
| Dec 31, 2023 | -195.07% |
| Sep 30, 2023 | -4.01% |
| Jun 30, 2023 | -21.75% |
| Mar 31, 2023 | 22.15% |
| Dec 31, 2022 | 120.68% |
| Sep 30, 2022 | -115.41% |
| Jun 30, 2022 | -525.28% |
| Mar 31, 2022 | -148.47% |
| Dec 31, 2021 | -520.92% |
| Sep 30, 2021 | 408.35% |
| Jun 30, 2021 | 17.21% |